Oxalate Transport Across The Renal Papilla: Implications in Sites and Mechanism of Initial Kidney Stone Formation

1994 ◽  
pp. 35-39
Author(s):  
P. S. Chandhoke ◽  
K. A. Hruska
Keyword(s):  
Kidney Stone ◽  
Stone Formation ◽  
Renal Papilla ◽  
Kidney Stone Formation ◽  
Oxalate Transport

The controversial association of gut and urinary microbiota with kidney stone formation

2021 ◽  
pp. 105257
Author(s):  
Narjess Bostanghadiri ◽  
Pardis Ziaeefar ◽  
Fatemeh Sameni ◽  
Mohammad Mahmoudi ◽  
Ali Hashemi ◽  
...  
Keyword(s):  
Kidney Stone ◽  
Stone Formation ◽  
Urinary Microbiota ◽  
Kidney Stone Formation

scholarly journals ANTIUROLITHIC ACTIVITY OF BERBERIS TRIFOLIATA EXTRACT ON INDUCED UROLITHIASIS IN RATS BY ZINC DISC IMPLANTATION

2017 ◽  
Vol 15 (1) ◽  
pp. 168
Author(s):  
Raymundo Alejandro Pérez-Hernández ◽  
Silvia Guadalupe Treviño-Moreno ◽  
Gilberto Arévalo- Martínez ◽  
Eduardo Sánchez -García ◽  
Catalina Leos-Rivas ◽  
...  
Keyword(s):  
Kidney Stone ◽  
Methanolic Extract ◽  
Stone Formation ◽  
Final Weight ◽  
The Difference ◽  
Postsurgical Recovery ◽  
Kidney Stone Formation ◽  
Treatment Of Urolithiasis ◽  
Different Doses

Background: In clinical therapy, there is no satisfactory drug available for treatment of urolithiasis, especially for the prevention of their recurrence. The aim of this work was to evaluate in vivo antiurolithic activity of methanolic extract of Berberis trifoliata leaves. Material and methods: Urolithiasis was induced in Wistar rats by zinc disc implantation in urinary bladder. Upon postsurgical recovery, different doses of the methanolic extract of B. trifoliata leaves (50, 100 and 150 mg/kg body weight) were administered orally to zinc disc implanted rats for a period of 20 days. Antiurolithiatic activity was evaluated by measuring the difference between the weight of the implanted zinc discs at the time of implantation and the final weight of the dried calculi taken out from the bladder at the end of the 20 days period of treatment. Results: Extract of B. trifoliata significantly reduced calculi deposition around the implanted zinc disc at all doses (50, 100, and 150 mg/kg). Conclusion: Treatment with methanolic extract of B. trifoliata is useful agent against the kidney stone formation.

scholarly journals PD31-10 STATIN INTAKE REDUCES KIDNEY STONE FORMATION

2016 ◽  
Vol 195 (4S) ◽  
Author(s):  
Andrew Cohen ◽  
Melanie Adamsky ◽  
Charles Nottingham ◽  
Jaclyn Pruitt ◽  
Brittany Lapin ◽  
...  
Keyword(s):  
Kidney Stone ◽  
Stone Formation ◽  
Kidney Stone Formation

Limited Risk of Kidney Stone Formation During Long-Term Calcium Citrate Supplementation in Nonstone Forming Subjects

1994 ◽  
Vol 152 (2 Part 1) ◽  
pp. 324-327 ◽  
Author(s):  
Khashayar Sakhaee ◽  
Sioni Baker ◽  
Joseph Zerwekh ◽  
John Poindexter ◽  
Pedro A. Garcia-Hernandez ◽  
...  
Keyword(s):  
Kidney Stone ◽  
Stone Formation ◽  
Calcium Citrate ◽  
Kidney Stone Formation

Cross-talk between renal lithogenesis and atherosclerosis: an unveiled link between kidney stone formation and cardiovascular diseases

2018 ◽  
Vol 132 (6) ◽  
pp. 615-626 ◽  
Author(s):  
Asokan Devarajan
Keyword(s):  
Risk Factors ◽  
Uric Acid ◽  
Cardiovascular Diseases ◽  
Kidney Stone ◽  
Arterial Wall ◽  
Stone Formation ◽  
Crystal Nucleation ◽  
Cvd Risk Factors ◽  
Cvd Risk ◽  
Kidney Stone Formation

The prevalence of kidney stones and cardiovascular diseases (CVDs) are increasing throughout the world. Both diseases are chronic and characterized by accumulation of oxidized proteins and lipids in the renal tissue and arterial wall, respectively. Emerging studies have revealed a positive association between nephrolithiasis and CVDs. Based on preclinical and clinical evidences, this review discusses: (i) stone forming risk factors, crystal nucleation, aggregation, injury-induced crystal retention, and stone formation, (ii) CVD risk factors such as dyslipidemia, perturbation of gut microbiome, obesity, free radical-induced lipoprotein oxidation, and retention in the arterial wall, subsequent foam cell formation, and atherosclerosis, (iii) mechanism by which stone forming risk factors such as oxalate, calcium, uric acid, and infection contribute toward CVDs, and (iv) how CVD risk factors, such as cholesterol, phospholipids, and uric acid, contribute to kidney stone formation are described.

Beyond Oxalobacter: the gut microbiota and kidney stone formation

Gut ◽  
2018 ◽  
Vol 67 (12) ◽  
pp. 2078-2079 ◽  
Author(s):  
Gwen Falony
Keyword(s):  
Gut Microbiota ◽  
Kidney Stone ◽  
Stone Formation ◽  
Kidney Stone Formation
Sign in / Sign up

Export Citation Format

Share Document